KFS
Kurt F. Somerville Portfolio holdings
AUM
$594M
This Quarter Return
-12.26%
1 Year Return
+12.39%
3 Year Return
+68.79%
5 Year Return
+108.17%
10 Year Return
+271.21%
AUM
$527M
AUM Growth
+$527M
(-15%)
Cap. Flow
+$3.21M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
39.77%
Holding
123
New
–
Increased
31
Reduced
50
Closed
4
Top Buys
| 1 |
Amazon
AMZN
|
$9.4M |
| 2 |
Medtronic
MDT
|
$1.9M |
| 3 |
NVIDIA
NVDA
|
$1.43M |
| 4 |
Edwards Lifesciences
EW
|
$775K |
| 5 |
Aptiv
APTV
|
$648K |
Top Sells
| 1 |
Unilever
UL
|
$5.68M |
| 2 |
Intel
INTC
|
$782K |
| 3 |
Apple
AAPL
|
$713K |
| 4 |
Microsoft
MSFT
|
$550K |
| 5 |
Novartis
NVS
|
$546K |
Sector Composition
| 1 | Healthcare | 27.14% |
| 2 | Technology | 23.39% |
| 3 | Industrials | 12.12% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Consumer Staples | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Honeywell
HON
$138B
| $7.42M | 1.41% |
42,665
+1,702
| +4% | +$296K |
|
27
Nike
NKE
$110B
| $7.22M | 1.37% |
70,646
+4,102
| +6% | +$419K |
|
28
Chevron
CVX
$326B
| $6.27M | 1.19% |
43,325
-915
| -2% | -$132K |
|
29
PepsiCo
PEP
$206B
| $6.1M | 1.16% |
36,625
+297
| +0.8% | +$49.5K |
|
30
PayPal
PYPL
$66.2B
| $4.84M | 0.92% |
69,245
+6,282
| +10% | +$439K |
|
|
31
NVIDIA
NVDA
$4.16T
| $4.62M | 0.88% |
30,472
+9,461
| +45% | +$1.43M |
|
32
Exxon Mobil
XOM
$489B
| $4.3M | 0.82% |
50,185
-400
| -0.8% | -$34.3K |
|
33
Illumina
ILMN
$15.8B
| $4.24M | 0.8% |
22,974
+54
| +0.2% | +$9.96K |
|
|
34
Medtronic
MDT
$120B
| $4.07M | 0.77% |
45,345
+21,190
| +88% | +$1.9M |
|
|
35
Unilever
UL
$156B
| $3.64M | 0.69% |
79,502
-123,849
| -61% | -$5.68M |
|
|
36
Intel
INTC
$106B
| $3.45M | 0.65% |
92,121
-20,906
| -18% | -$782K |
|
37
iShares Core S&P 500 ETF
IVV
$657B
| $2.9M | 0.55% |
7,660
| – | – |
|
38
AbbVie
ABBV
$374B
| $2.58M | 0.49% |
16,852
-1,366
| -7% | -$209K |
|
|
39
Edwards Lifesciences
EW
$47.8B
| $2.32M | 0.44% |
24,350
+8,153
| +50% | +$775K |
|
|
40
Aptiv
APTV
$17.3B
| $2.16M | 0.41% |
24,210
+7,275
| +43% | +$648K |
|
41
Merck
MRK
$214B
| $2.15M | 0.41% |
23,625
-50
| -0.2% | -$4.56K |
|
42
Eli Lilly
LLY
$659B
| $1.79M | 0.34% |
5,531
-164
| -3% | -$53.2K |
|
43
Norfolk Southern
NSC
$62.4B
| $1.47M | 0.28% |
6,455
| – | – |
|
44
Novo Nordisk
NVO
$251B
| $1.44M | 0.27% |
12,912
-2,340
| -15% | -$261K |
|
45
Visa
V
$679B
| $1.37M | 0.26% |
6,976
-50
| -0.7% | -$9.84K |
|
46
Colgate-Palmolive
CL
$67.9B
| $1.35M | 0.26% |
16,842
| – | – |
|
47
EOG Resources
EOG
$68.8B
| $1.34M | 0.25% |
12,157
-763
| -6% | -$84.3K |
|
48
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.3M | 0.25% |
4,744
-75
| -2% | -$20.5K |
|
49
Coca-Cola
KO
$297B
| $1.29M | 0.25% |
20,527
-850
| -4% | -$53.5K |
|
50
Union Pacific
UNP
$133B
| $1.17M | 0.22% |
5,502
+219
| +4% | +$46.7K |
|